Skip to main content

The role of medical thoracoscopic lung biopsy in diagnosis of diffuse parenchymal lung diseases

Abstract

Background

Interstitial lung disease in the immunocompetent patient is often a difficult challenge for the clinician, especially when no diagnostic clues are present. A clear diagnosis confirmed by biopsy allows clinicians and patients to discuss fully the implications of the disease.

Aim

The aim was to evaluate the role of medical thoracoscopic lung biopsy in diagnosis of patients with diffuse parenchymal lung diseases.

Patients and methods

The study included 15 patients with diffuse parenchymal lung diseases of unknown etiology. They had undergone full history taking, complete clinical examination, ventilatory function tests (spirometry), arterial blood gases analysis, high-resolution computed tomography chest, coagulation profile, platelet count, collagen profile, and thoracoscopic lung biopsy by medical thoracoscopy for histopathologic examination. Follow-up of the patients in the inpatient unit was done by chest radiography and clinical evaluation.

Results

The pathological diagnosis of cases was six (40%) patients with extrinsic allergic alveolitis, five (33.3%) patients with malignancy, three patients with idiopathic interstitial pneumonias, one (6.7%) patient with tuberculosis, and one (6.7%) patient with sarcoidosis. Regarding complications, one (6.7%) patient had pneumothorax after intercostal tube (ICT) removal, and three (20%) patients had subcutaneous emphysema. The duration of the ICT drainage was 3.1±2.6 days. There was no wound infection, no bleeding, no persistent air leak after more than 24 h (Hs) from ICT insertion, no respiratory failure requiring ICU admission, and no mortality in the study sample.

Conclusion

Thoracoscopic lung biopsy by medical thoracoscopy is useful in diagnosis of cases with diffuse parenchymal lung diseases of unknown etiology when lung biopsy is needed for accurate diagnosis. The procedure is safe. The procedure carries some complications that are not life threatening and can be minimized by good selection of patients.

References

  1. Raghu G. Interstitial lung disease diagnostic approach. Are CT scan and lung biobsy indicated in every patient. AM J Respir Crit Care Med 1995; 151:909–991.

    Article  CAS  Google Scholar 

  2. Viskum K, Enk B. Complications of thoracoscopy. Poumon Coeur 1981; 37:25–28.

    CAS  PubMed  Google Scholar 

  3. Mathur P, Astoul P, Boutin C. Medical thoracoscopy. Technical details. Clin Chest Med 1995; 16:479–486.

    CAS  PubMed  Google Scholar 

  4. Vansteenkiste J, Verbeken E, Thomeer M, Van Haecke P, Eeckhout AV, Demedts M. Medical thoracoscopic lung biopsy in interstitial lung disease:a prospective study of biopsy quality. Eur Respir J 1999; 14:585–590.

    Article  CAS  Google Scholar 

  5. Shoukri A. Medical thoracoscopy:past, present, and future. Egypt J Bronchol 2013; 7:50.

    Article  Google Scholar 

  6. Elhadidy T, Ibrahim M, Moustafa F, Elmaksoud A. Video assisted medical thoracoscopic lung biopsy in diagnosis of diffuse pulmonary infiltrate. Egypt J Chest Dis Tuberc 2016; 66:PA2493.

  7. Elbadrawy MF, Fathy AM, Amin MM, Abodda MA, Alsaid AR. Transbronchial lung biopsy and bronchoalveolar lavage in diagnosis of diffuse pulmonary infiltrates. Egypt J Chest Dis Tubercul 2006; 56:66–72.

    Google Scholar 

  8. Danes C, Gonzalez JM, Pumarola T, Rano A, Benito N, Puig J. Pulmonary infiltrates in immunocompromised patients. Am Soc Immunol 2002; 40:2134–2140.

    Google Scholar 

  9. Jain P, Sandur S, Meli Y, Arroliga AC, Stoller JK, Mehta AC. Role of flexible bronchoscopy in immune compromised patients with lung infiltrates. Chest 2004; 125:712–722.

    Article  Google Scholar 

  10. Xaubet A, Anochea J, Morell F, Rodriguez-Arias JM, Villena V, Blanquer R, et al. Report on the incidence of interstitial lung disease in Spain. Sarcoidosis Vasc Diffuse Lung Dis 1998; 21:64–70.

    Google Scholar 

  11. Erbes R, Schaberg T, Loddenkamper R. Lung function tests in patients with pulmonary fibrosis:Are they useful for predicting outcome. Chest 1997; 111:51–57.

    Article  CAS  Google Scholar 

  12. Yang S, Raghu G. Clinical evaluation. In:Costabel U, duBois RM, Egan MM, editors. Diffuse parenchymal lung disease. Basel (Switzerland):Karger; 2007. 22–28.

  13. Morell F, Reyes L, Domench G, Gracia J, Majo J, Ferrer J. Diagnosis and diagnostic procedures in 500 consecutive patients with clinical suspension of interstitial lung diseases. Arch Bronchoneumol 2008; 44:185–191.

    Google Scholar 

  14. Agostini C, Albera C, Barifi F, Harari S, Lusuardi M. First report of the Italian register for diffuse infiltrative lung disorders. Mondali Arch Chest Dis 2001; 56:364–368.

    CAS  Google Scholar 

  15. Boutin C, Viallat J, Cargnino P, Rey F. Thoracoscopic lung biopsy. Experimental and clinical preliminary study. Chest 1982; 82:44–48.

    Article  CAS  Google Scholar 

  16. Rodgers B, Moazam F, Talbert J. Thoracoscopy:early diagnosis of interstitial pneumonitis in the immunologically suppressed child. Chest 1979; 75:126–130.

    Article  CAS  Google Scholar 

  17. Dijkman J, van der Meer J, Bakker W, Wever A, van der Broek P. Transpleural lung biopsy by the thoracoscopic route in patients with diffuse interstitial pulmonary disease. Chest 1982; 82:76–83.

    Article  CAS  Google Scholar 

  18. Elnady M, Shalaby A, Mohammad A. Evaluation of safty and feasibility and usefulness of thoracoscopic lung biopsy by medical thoracoscopy in diffuse lung infiltrates. Chest 2012; 435a 435b.

  19. Kapsenberg P. Thoracoscopic biopsy under visual control. Poumon Coeur 1981; 37:313–316.

    CAS  PubMed  Google Scholar 

  20. Nitin A. Evaluation of lung biopsy techniques for diagnosis of diffuse interstitial infiltrates. ERS Annual Conference 2006; 740. E-Poster.

  21. Brandt H. Biopsiepulmonare sous controle de la vue. Poumon Coeur 1981; 37:301–313.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Etemad Abdelsalam MBBCH, MSC, MD chest.

Additional information

This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.

Rights and permissions

This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Omar, M.M., Alhalafawy, A.S., Emara, N.M. et al. The role of medical thoracoscopic lung biopsy in diagnosis of diffuse parenchymal lung diseases. Egypt J Bronchol 13, 155–161 (2019). https://doi.org/10.4103/ejb.ejb_41_18

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.4103/ejb.ejb_41_18

Keywords